Primary Prevention of Cardiovascular Disease in People with HIV: The REPRIEVE Trial

Publish date:

January 12, 2024

AETC Source

Training slides describe how to apply new REPRIEVE trial data in clinical practice, highlighting the need for primary prevention of cardiovascular disease in people with HIV.

Preview and Download

pptx

Preview

Download

Primary Prevention Cardiovascular Disease with PWH-The Reprieve Trial

Browse more

Languages

English

Topic(s)

Co-occurring Conditions

Type

Trainer Resources

Bimonthly Survey

What is your primary profession/discipline

Other Non-Clinical Professional

Other Allied Professional

What is your primary functional role?

Specify Other Role

In what state or territory is your primary worksite?

If you use phone-based apps in your professional life, what type do you use?

Select all that apply

Medication information (dosages, interactions)

Clinical reference (screening and treatment algorithms)

Clinical calculators

Community resources for referrals

I use search engines, but don't use apps

I use a computer if I need to look things up, not my phone

Other uses

To what extent have the resources and trainings available through this website increased your knowledge and skills to provide care for people with HIV?